AzTrials
AzTrials

Low Back PainNCT05077566

Immediate Exercise-Induced Hypoalgesia in Patients With Chronic Low Back Pain

A study testing Exercise at 60% vo2 and Exercise at 90% vo2 in people with Low Back Pain, run by Aveiro University at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of this study is: To evaluate the immediate hypoalgesic effect of an aerobic exercise session of different intensities in patients with chronic low back pain; The secondary objective is: To explore whether pain intensity, level of physical activity, functionality, catastrophizing, kinesiophobia… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Low Back Pain
What is being tested?
Exercise at 60% vo2 and Exercise at 90% vo2
Could I receive a placebo?
No, everyone receives an active treatment
How many people
83 participants
Where
1 sitePortugal
Study dates
3 Oct 2021to 15 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All groups:
  • age between 18 and 65 years old
  • Participants with low back pain:
  • non-specific LBP (defined as pain between the costal margins and the inferior gluteal folds, which is usually accompanied by painful limitation of movement and may be associated with pain referred down to the leg)

Who cannot join

  • All groups:
  • presence of pathology of the nervous system, cardiovascular or carcinogenic, rheumatic diseases (for example, rheumatoid arthritis), fibromyalgia, previous history of lumbar surgery, medication that affects or alters heart rate, any contraindication to exercise and pregnancy.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Private Clinics of Physiotherapy

    Aveiro

Other trials in Portugal

About this study

The main objective of this study is:

  • To evaluate the immediate hypoalgesic effect of an aerobic exercise session of different intensities in patients with chronic low back pain;

The secondary objective is:

  • To explore whether pain intensity, level of physical activity, functionality, catastrophizing, kinesiophobia, anxiety and depression interfere with the immediate hypoalgesic effect of exercise.
Read the detailed description

There will be 3 groups of participants, an asymptomatic control group that will not perform any exercise and two groups of individuals with low back pain. One group will perform exercise at 90% VO2máx and the other at 60% VO2máx.

All the three groups will be assessed at baseline for pressure pain threshold, pain intensity, pain phenotype, disability, kinesiophobia, catastrophizing, anxiety and depression, physical activity, and aerobic capacity. In addition, pressure pain threshold and pain intensity will also be assessed at post-intervention.

Conditions
Low Back Pain
Being tested
Exercise at 60% vo2, Exercise at 90% vo2
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise at 60% vo2Other

    15 minutes of exercise at 60% VO2 max.

  • Exercise at 90% vo2Other

    15 minutes of exercise at 90% VO2 max.

Study groups in NCT05077566
Study groupRoleWhat they receive
Exercise at 60% vo2Active comparatorThis arm will receive 15 minutes of exercise at 60% VO2 max.
Receives: Other: Exercise at 60% vo2
Exercise at 90% vo2ExperimentalThis arm will receive 15 minutes of exercise at 90% VO2 max.
Receives: Other: Exercise at 90% vo2
No interventionNo interventionNo intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure pain threshold

    Pressure pain threshold measured with an algometer in Kgf

    Measured: Baseline

  2. Pressure pain threshold

    Pressure pain threshold measured with an algometer in Kgf

    Measured: Post-intervention (approximately 45 minutes after baseline)

Secondary outcomes (10)
  1. Aerobic capacity

    Measured with the Chester Step Test (CST) which gives aerobic capacity and allows the calculation of percentage of VO2 max.

    Measured: Baseline

  2. Physical activity

    Measured with the International Physical Activity Questionnaire. Results can be reported in categories (low activity levels, moderate activity levels or high activity levels) or as a continuous variable (MET minutes a week).

    Measured: Baseline

  3. Anxiety and depression

    Measured with the Hospital Anxiety and Depression Scale. This scale has 2 subscales, one for Anxiety and one for Depression both scored 0 to 21 and higher values represent higher levels of anxiety and depression.

    Measured: Baseline

  4. Catastrophizing

    Measured with the Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)

    Measured: Baseline

  5. Fear of movement

    Measured with the TAMPA Scale of Kinesiophobia (range: 13-52 and higher values are indicative of higher levels of fear of movement)

    Measured: Baseline

  6. Disability

    Measured with the Roland Morris Disability Questionnaire (range: 0 to 24, with higher values indicating higher disability)

    Measured: Base

  7. Pain phenotype

    Measured with the Pain DETECT Scale. The final score between -1 and 38, indicates the likelihood of a neuropathic pain component. A score of ) 12 indicates that pain is unlikely to have a neuropathic component (< 15%), while a score of * 19 suggests that pain is likely to have a neuropathic component (> 90%).

    Measured: Baseline

  8. Symptoms of central sensitization

    Measured with the Central Sensitization Inventory. Score ranges from 0 to 100 and higher scores indicate higher symptoms of central sensitization.

    Measured: Baseline

  9. Pain intensity

    Assessed using the Visual Analogue Scale from 0 to 100 mm

    Measured: Baseline

  10. Pain intensity

    Assessed using the Visual Analogue Scale from 0 to 100 mm

    Measured: Post-intervention (approximately 45 minutes after baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2021
  2. Study start3 Oct 2021
  3. Primary completion1 Aug 2022
  4. Study completion15 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
83 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05077566
Sponsor's protocol ID
CED8_2021
Status last verified
Feb 2023
First submitted
1 Oct 2021
Last updated
21 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise at 60% vo2 and Exercise at 90% vo2 in people with Low Back Pain, run by Aveiro University at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure pain threshold (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in